Vimentin antibody production in transplant patients and immunomodulatory effects of vimentin in-vitro.

Abstract excerpt

We investigated the presence of antibodies to vimentin in 150 patients awaiting transplant, (50 kidney, 50 liver and 50 thoracic) and in 51 previously transplanted kidney patients whose grafts had failed. Patients with primary end stage thoracic or kidney disease did not have increased levels of vimentin antibodies, but those with primary liver failure and those with kidney graft failure did. Those with kidney...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Antibody Formation
• Share to Graft Rejection
• Share to Immunomodulation